<DOC>
	<DOCNO>NCT02272569</DOCNO>
	<brief_summary>Prospective , Non-comparative , Multi-center clinical trial evaluate safety efficacy STARflo Glaucoma Implant patient refractory open angle glaucoma .</brief_summary>
	<brief_title>STARflo European Safety Efficacy Study</brief_title>
	<detailed_description>This prospective , multicenter clinical trial ass efficacy safety STARflo™ Glaucoma Implant . Patients enter study provide write informed consent . Patients screen confirm eligible study participation . When eligibility establish use in/exclusion criterion , surgery schedule . Pre post-surgery , patient evaluate scheduled interval ( 1 day , 1 week , 1 month , 3 month , 6 month , 12 month ) total duration 12 month follow surgery .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Main Diagnosis refractory open angle glaucoma Documented 21 mmHg &lt; IOP ≤ 40 mmHg , medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>glaucoma drainage device</keyword>
	<keyword>glaucoma shunt</keyword>
</DOC>